Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Effects of electrical stimulation on fatigue in healthy individuals

Official title: Neuromodulation and Its Effects on Muscle Activity and Fatigue

Run by University of Oklahoma · NCT05487131 · Data updated 2026-11-12

This study tests if a mild electrical current applied to the neck can help healthy adults feel less tired and improve their muscle performance.

More Fatigue trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Oklahoma
Academic / other
Locations1 site (Norman, Oklahoma)
StatusRecruiting
StartedJune 3, 2023
Main results expectedSeptember 2027
Study endsDecember 2027
Registry record updatedApril 9, 2026
Trial IDNCT05487131 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are healthy individuals aged 18 to 50 without any neuromuscular diseases or metal implants.

Probably not a fit

Patients with metal implants, joint replacements, or skin hypersensitivity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the impact of transcutaneous spinal direct current stimulation (TsDCS) on functional capacity and muscle activation in healthy individuals aged 18 to 50. Participants will undergo one familiarization session followed by three experimental sessions where their fatigability and motor function will be assessed. The study aims to explore how a weak electrical current applied to the neck or thoracic area influences fatigue levels and muscle performance.

Why it matters

Potential benefit: If successful, this study could provide insights into non-invasive methods to enhance functional capacity and reduce fatigue in healthy individuals.

How similar studies have gone: While the approach of using electrical stimulation for fatigue is explored in various contexts, this specific application in healthy aging is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Healthy individuals between 18 and 50 years old

Exclusion Criteria:

Metal implants or joint replacement. Presence of neuromuscular disease. Skin hypersensitivity.

Where it's running

  • University of Oklahoma
    Norman, Oklahoma, United States
    Recruiting

Study contacts

  • Principal investigator: Hugo Pereira, PhD — University of Oklahoma
  • Study coordinator: Hugo Pereira, PhD
  • Email: hugomax@ou.edu
  • Phone: 405-325-2773

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Remote Ischaemic Conditioning for Fatigue After Stroke 2

    Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

    Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

  • Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?

    This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.

    Recruiting Applied Science & Performance Institute · Tampa, Florida · NCT07760506

  • NVTIA Ergothioneine for Healthy Aging and Skin Health

    This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.

    Recruiting European Life Science Research Association · Dhaka · NCT07750002

  • Micro-choice-based approach to fatigue management

    A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.

    Recruiting University Hospital, Basel, Switzerland · Basel · NCT07726082

  • Miricell supplementation and markers of healthy aging

    This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.

    Recruiting Nutraland USA, Inc. · Canfield, Ohio · NCT07675200

  • HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults

    This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.

    Recruiting at 29 sites Phase 3 Harmony Biosciences Management, Inc. · Birmingham, Alabama and 52 other locations · NCT07675135

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.